The US Food and Drug Administration (FDA) has granted approval for Dilon Technologies’ MarginProbe 2, a next-generation intraoperative margin assessment device for use in breast cancer surgery, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback